Rothia mucilaginosa Infections in Pediatric Cancer Patients-Reference-Cited by-同舟云学术

Rothia mucilaginosa Infections in Pediatric Cancer Patients

Published:2020-05-25 Issue:3 Volume:10 Page:341-344
ISSN:2048-7207
Container-title:Journal of the Pediatric Infectious Diseases Society
language:en
Short-container-title:

Author:

Getzenberg Rachel B¹,Hijano Diego R²^ORCID,Hakim Hana²,Dallas Ronald H²,Ferrolino Jose A²,Brazelton de Cardenas Jessica³,Garner Cherilyn D³,Tang Li⁴,Su Yin⁴,Wolf Joshua²,Hayden Randall T³,Maron Gabriela²

Affiliation:

1. University of Tennessee Health Science Center, Memphis, Tennessee, USA

2. Department of Infectious Diseases, St Jude Children’s Research Hospital, Memphis, Tennessee, USA

3. Department of Pathology, St Jude Children’s Research Hospital, Memphis, Tennessee, USA

4. Department of Biostatistics, St Jude Children’s Research Hospital, Memphis, Tennessee, USA

Abstract

Abstract We performed a retrospective study to determine the epidemiology of Rothia mucilaginosa infections among pediatric cancer patients. Over 20 years, 37 cases were identified; 27% developed complications, but there was no infection-related mortality. All cases were successfully treated with vancomycin.

Funder

National Institutes of Health

St Jude Pediatric Oncology Education Program and American Lebanese Syrian Associated Charities

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,General Medicine,Pediatrics, Perinatology and Child Health

Link

http://academic.oup.com/jpids/article-pdf/10/3/341/38837840/piaa047.pdf

Reference12 articles.

1. DNA pyrosequencing-based bacterial pathogen identification in a pediatric hospital setting;Luna;J Clin Microbiol,2007

2. Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients;McWhinney;Clin Infect Dis,1992